Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 834 participants.

Also called NCT03317197

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 834 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03317197
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03317197. Randomized; double masking; primary purpose treatment. Start 2018-01-01 (anticipated); primary completion 2020-08-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest
Intervention (Drug)
Control Group
Intervention (Drug)
Experimental Group 1
Intervention (Drug)
Experimental Group 2
Intervention (Drug)
Experimental Group 3
Lead sponsor
Korea University Guro Hospital (class: other)

Record details

Record id
cardio:ct-nct03317197
Content hash
596029f47ba072967e16c7cb88a9ce2e9b2b47e2f7c30ced8ccfec32941a558a